TRI TrivarX Limited
—Mkt Cap: —P/E: —1d ago
TrivarX Limited, a biotechnology company, engages in the development of AI-driven, and scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. It is al…
Industry Peers
Health Information Services$50.68BUSDP/E 52.1
$12.83BUSD
$12.34BUSDP/E 55.2
$8.47BUSDP/E 34.6
$7.65BUSDP/E 33.5
$5.61BUSDP/E 37.1
$5.41BUSDP/E 39.2
$4.43BUSD
$2.89BUSDP/E 107.7
$1.91BUSD
$1.64BUSDP/E 43.8
$1.47BUSD
$1.20BUSDP/E 70.1
$1.14BUSDP/E 77.8
$1.08BUSD
$1.03BUSDP/E 46.9
$685.26MUSDP/E 64.9
$620.58MUSD
$594.53MUSD
$580.72MUSDP/E 31.4
Key Statistics
Company
Market Cap—
Enterprise Value4.78M USD
Revenue (TTM)10.07K USD
Gross Profit10.07K USD
Net Income (TTM)-6.06M USD
Revenue/Share0.00 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryHealth Information Services
ISINAU0000300196
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.06
EV/Revenue474.69
P/S633.64
P/B0.57
EPS (TTM)-0.76
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin315936.13%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-61.23%
ROA-35.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.04M USD
CapEx (TTM)1.97M USD
FCF Margin3446.53%
FCF Yield—
Net Debt-1.60M USD
Net Debt/EBITDA0.69
Balance Sheet
Debt/Equity0.00
Current Ratio5.26
Quick Ratio5.16
Book Value/Sh0.01 AUD
Cash/Share0.0020 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateOct 24, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.15B
Float901.38M
Insiders25.33%
Institutions6.76%
Technical
SMA 500.0127 AUD
SMA 2000.0192 AUD
Beta1.04
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)476.09K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—